Platelet-rich plasma is a non-surgical alternative to potential cure areas, such as orthopedics, sports medicine, dentistry, ENT, neurosurgery, ophthalmology, urology, and wound healing; as well as cosmetic, cardiothoracic, and maxillofacial surgery. Platelet concentration systems are designed for safe and rapid preparation of platelet rich plasma at the point of care from a small amount of patient’s blood sample.
For Critical Insights, Request for Sample@ https://www.futuremarketinsights.com/reports/sample/rep-gb-1536
Platelet-rich plasma (PRP) is a regenerative injection therapy that stimulates the body’s natural healing process. Platelet Rich Plasma is a plasma fraction of autologous blood which has been enriched with platelets by specialized equipment.
Through centrifugal force, these concentrated systems provide high platelet yield while maintaining the delicate buffy coat. This buffy coat is returned to the patient while suspended in the plasma volume. The concentration of platelets in PRP can vary from four to eight times, depending on the system used to prepare it.
Furthermore, a lot of the systems on the market today enable the collection of platelet-poor plasma, which can then be given to patients as an autologous fibrin product for topical homeostasis. Because of advancing technology and expanding use of PRP therapy in sports medicine, the market for platelet concentration systems is anticipated to expand quickly.
The main factors driving the development of platelet concentration systems are the increasing incidence of musculoskeletal injuries and the expansion of PRP therapy in sports medicine. The European Injury Data Base estimates that 4.5 million adults aged 15 and older receive annual treatment for sports-related injuries in EU hospitals.
In the upcoming years, the use of technologically advanced platelet concentration systems in the creation of autologous blood concentrate would hasten the spread of these devices. In just two and a half minutes, the PEAK PRP System (DePuy) can produce 3 ml of highly concentrated PRP from 27 ml of whole blood.
However, in the near future, fierce competition from regional producers might have an impact on the market expansion of platelet concentration systems as a whole.
Due to the rising number of sports-related injuries, North America currently holds the largest market share for the use of platelet concentration systems, followed by Europe and Asia Pacific. According to the European Commission, musculoskeletal injuries account for 15–25% of primary care consultations in Europe each year.
By promoting secure and efficient wound healing, platelet rich plasma therapy is an appealing and promising alternative to surgery for treating musculoskeletal injuries like tennis elbow, achilles tendinopathy, and plantar fasciitis.
However, is anticipated to gain traction in the upcoming years with the development of sophisticated R&D infrastructure in emerging regions like APAC. Along with regulatory harmonisation, other factors that are anticipated to have a significant impact on the growth of platelet concentration systems include rising patient awareness and affordability levels.
Inquire Before Buying Research Report@
https://www.futuremarketinsights.com/askus/rep-gb-1536
Platelet Concentration Systems Market: Market Players
Some of the key market players in the global platelet concentration systems includes, Anthrax Inc., Stryker Corporation, Johnson & Johnson’s, Zimmer Biomet Holdings Inc., Terumo Corporation, Arteriocyte Medical Systems, Inc., Glofinn Oy., Exactech Inc., Harvest Technologies Corp., Nuo Therapeutics, Inc., Regen Lab SA,
Platelet Concentration Systems Market
The global platelet concentration system market is segmented on the basis of technology, end user and regions.
Segmentation by Technology
- Apheresis Technology
- Single Spin Technology
- Double Spin Technology
Buy Now@ https://www.futuremarketinsights.com/checkout/1536
Segmentation by End User
- Hospitals
- Orthopedic Clinics
- Sports injury centers
- Ambulatory Surgical Centers
About Future Market Insights (FMI)
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs